Mark Ahn (via PR Newswire)

For­mer Gale­na chief Mark Ahn back in hot wa­ter as DOJ lev­els in­sid­er trad­ing charges for con­sul­tant work

When Mark Ahn de­part­ed trou­bled Gale­na Phar­ma­ceu­ti­cals back in 2014, he told in­vestors he look­ing to pur­sue oth­er “long-held” goals. Turns out one of those goals may al­leged­ly have been ped­dling stock based on in­sid­er in­fo.

The DOJ on Mon­day charged Ahn, Gale­na’s for­mer CEO, with two counts of se­cu­ri­ties fraud af­ter he al­leged­ly bought a biotech’s stock based on non­pub­lic in­for­ma­tion about the com­pa­ny’s in­tent to sell, which he ac­quired as a con­sul­tant.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.